MVAIF yields 2267.57% · PFE yields 6.13%● Live data
📍 MVAIF pulled ahead of the other in Year 1
Combined, MVAIF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MVAIF + PFE for your $10,000?
Minerva Intelligence Inc., a software development company, provides proprietary AI software and related consulting services. Its principal products include DRIVER uses Machine Learning-based statistical models to automate and accelerate 3D modelling of drilling datasets; Language Extender and Organizer uses controlled vocabularies to automatically index and tag its files, making document management, and searchable, as well as a system for managing a corporation's digital knowledge assets; TARGET, a cognitive AI system that produces explainable exploration targets by mimicking the traditional process of geological data evaluation; SOLACE enables organizations to create and curate standards and design self-improving workflows to align current and future datasets. The company also offers Aristotelian Class Editor, a free software application developed to build taxonomies for use in artificial intelligence applications. In addition, it provides climate85 solutions to enhance the understanding of impacts of climate changes, to adapt and identify opportunities for various industries; and TERRA mining AI platform. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
Full MVAIF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.